Table 1 Characteristics of patients at time of blood collection by HIV status – Burkina Faso, Côte d’Ivoire and Mali – IeDEA West Africa cohort (2012)
Variables | Total | HIV-1 | HIV-2 | HIV-1&2 | P-value |
|---|---|---|---|---|---|
N = 791 | N = 192 | N = 447 | N = 152 | ||
Age (years) | |||||
Median [IQR] | 47 [40–53] | 45 [37–51] | 49 [42–54] | 47 [42–52] | 0.0004 |
≤ 30 | 40 (5.1) | 14 (7.3) | 25 (5.6) | 1 (0.7) | <0.001 |
31–49 | 438 (55.4) | 112 (58.3) | 224 (50.1) | 102 (67.1) | |
≥ 50 | 313 (39.5) | 66 (34.4) | 198 (44.3) | 49 (32.2) | |
Gender | |||||
Male | 319 (40.3) | 76 (39.9) | 192 (43.0) | 51 (33.6) | 0.12 |
Female | 472 (59.7) | 116 (60.4) | 255 (57.1) | 101 (66.5) | |
Country | |||||
Burkina Faso | 232 (29.3) | 70 (36.4) | 81 (18.1) | 81 (53.3) | <0.001 |
Côte d’Ivoire | 535 (67.7) | 116 (60.4) | 350 (78.3) | 69 (45.4) | |
Mali | 24 (3.0) | 6 (3.1) | 16 (3.4) | 2 (1.3) | |
CD4 count (cells/mm3) | |||||
Median [IQR] | 472 [294–644] | 405 [276–599] | 488 [311–675] | 448 [295–615] | 0.0001 |
≤ 200 | 115 (14.5) | 32 (16.7) | 64 (14.3) | 19 (12.5) | 0.54 |
> 200 | 676 (85.5) | 160 (83.3) | 383 (85.7) | 133 (87.5) | |
Antiretroviral treatment | |||||
No | 236 (29.8) | 20 (10.4) | 191 (42.7) | 25 (16.5) | <0.0001 |
Yes | 555 (70.2) | 172 (89.6) | 256 (57.3) | 127 (83.6) | |
Antiretroviral regimena | |||||
Triple NRTI | 26 (4.7) | 8 (4.7) | 13 (5.1) | 5 (3.9) | 0.95 |
NRTI + NNRTI | 7 (1.3) | 3 (1.7) | 3 (1.2) | 1 (0.8) | |
NRTI + PI | 522 (94.0) | 161 (93.6) | 240 (93.7) | 121 (95.3) | |
Antiretroviral drugsa | 0.34 | ||||
3TC alone | 406 (73.2) | 131 (76.1) | 177 (69.2) | 98 (77.2) | |
TDF + 3TC (FTC) | 121 (21.8) | 34 (19.8) | 62 (24.2) | 25 (19.7) | |
Others | 28 (5.0) | 7 (4.1) | 17 (6.6) | 4 (3.1) | |